SPIR enters the week with a sharp disconnect at its centre: the stock has cratered 24% in five days to $16.26, yet every analyst covering the name holds a Buy rating and Stifel just lifted its target to $24 last week.
The most striking feature of this week's setup is how far the price has moved from what the Street believes it is worth. Stifel's Erik Rasmussen raised his target to $24 on June 4 — the most recent move from a covering firm — and Canaccord Genuity pushed its own target to $22.50 in May. The consensus mean sits at $20.875, implying roughly 28% upside from Tuesday's close. That gap has widened dramatically in a single week, and no analyst has yet pulled a rating or cut a target in response to the selloff. The bull case rests on 44% year-over-year revenue growth (excluding the divested maritime business), NATO defense spending tailwinds, and a long-run gross margin target of 60–70%. Bears point to negative free cash flow, a material weakness in financial reporting controls, and customer concentration risk — a reminder that revenue growth at this stage is not the same as financial health.
Short positioning tells a more nuanced story than the price action implies. Short interest is running at 12.7% of free float — elevated in absolute terms, but it has actually fallen roughly 26% over the past month, from a peak near 5.8 million shares in early May to around 4.2 million now. The borrow market has loosened considerably alongside that reduction: cost to borrow has halved since late April, dropping from above 7% to just 2.7%, its lowest level in the 30-day window. Availability has expanded to around 106% — meaning shares available to lend now roughly match the total already borrowed — compared to just 38% in early May when the borrow was genuinely tight. The short score from ORTEX registers at 65.9, elevated but tracking lower from the 67–68 range it held through late May. The overall picture is one of shorts covering into strength, not building new positions into a falling stock.
Options positioning offers no meaningful confirmation of the selloff's severity. The put/call ratio is running at 0.41, almost exactly in line with its 20-day average of 0.42, and a long way below its 52-week high of 1.23. Options traders, in other words, are not rushing for downside protection despite the 24% weekly loss. That absence of options-driven defensive positioning is worth noting: either the market sees the move as overdone, or hedging demand simply hasn't caught up with the price action yet. The PCR z-score of -0.15 confirms there is no statistical deviation from recent norms.
The insider picture adds a layer of caution. Every named executive sold shares on May 20 at prices around $19 — CEO Theresa Condor sold roughly 24,600 shares across two transactions, the founder and Executive Chairman Peter Platzer sold around 7,200 shares, CFO Alison Engel sold just over 12,700, and COO Celia Perez sold about 4,660. The combined net insider activity over the trailing 90 days reflects net selling of approximately $2.2 million in aggregate value. Those transactions occurred at $19, more than 15% above where the stock closed this week, which softens the bearish read somewhat — the sales may well have been scheduled disposals rather than a directional signal. That said, no insider buying is visible in the dataset to provide a counter-narrative.
Close peer BKSY fell 28% on the week and PL dropped 35%, suggesting sector-wide pressure on commercial satellite and geospatial names rather than a SPIR-specific catalyst. The next scheduled event is earnings on August 12, which gives the stock roughly nine weeks to re-anchor around either the analyst targets or the new lower price level — whichever the next data points support.
See the live data behind this article on ORTEX.
Open SPIR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
